Cochlear (ASX:COH) - Prezzo delle azioni, notizie e analisi

COH Panoramica delle azioni

Cochlear Limited fornisce soluzioni uditive impiantabili per bambini e adulti in tutto il mondo. Maggiori dettagli

COH analisi fondamentale
Punteggio fiocco di neve
Valutazione	0/6
Crescita futura	3/6
Prestazioni passate	3/6
Salute finanziaria	6/6
Dividendi	0/6

Premi

Il rapporto prezzo/utile ( 53.7 x) è inferiore alla media del settore Medical Equipment ( 54.7 x)

Si prevede che gli utili cresceranno del 11.67% all'anno

Gli utili sono cresciuti del 22.8% all'anno negli ultimi 5 anni

Analisi del rischio

COH ha superato i nostri controlli di rischio.

Cochlear Limited Concorrenti

Sonic Healthcare

ASX:SHL

AU$13.3b

Ramsay Health Care

ASX:RHC

AU$8.7b

Austco Healthcare

ASX:AHC

AU$87.4m

Ansell

ASX:ANN

AU$4.7b

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per Cochlear
Prezzi storici delle azioni
Prezzo attuale dell'azione	AU$293.02
Massimo di 52 settimane	AU$350.31
Minimo di 52 settimane	AU$258.25
Beta	0.46
1Variazione di 1 mese	2.63%
Variazione a 3 mesi	-4.39%
Variazione di 1 anno	12.59%
3Variazione a 3 anni	27.88%
Variazione a 5 anni	25.37%
Variazione dall'IPO	9,832.88%

Notizie e aggiornamenti recenti

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Nov 19

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 04

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Oct 18

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

Sep 19

Recent updates

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Nov 19

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Nov 04

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Oct 18

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

Sep 19

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Aug 16

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Oct 04

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Sep 12

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Jun 05

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Apr 05

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Mar 04

Is Cochlear (ASX:COH) A Risky Investment?

Dec 19

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

Nov 16

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Oct 25

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Oct 11

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Aug 28

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Aug 23

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Jul 16

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

May 19

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Apr 09

Estimating The Intrinsic Value Of Cochlear Limited (ASX:COH)

Feb 04

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal

Dec 24

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Oct 30

This Is Why We Think Cochlear Limited's (ASX:COH) CEO Might Get A Pay Rise Approved By Shareholders

Oct 12

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Oct 06

Returns On Capital Signal Tricky Times Ahead For Cochlear (ASX:COH)

Aug 16

Cochlear (ASX:COH) Has A Pretty Healthy Balance Sheet

Jun 24

A Look At The Intrinsic Value Of Cochlear Limited (ASX:COH)

May 17

Rendimenti per gli azionisti

	COH	AU Medical Equipment	AU Mercato
7D	-0.9%	0.5%	1.5%
1Y	12.6%	14.2%	17.2%

Ritorno vs Industria: COH ha avuto una performance inferiore rispetto al Australian Medical Equipment che ha registrato un rendimento 14.2 % nell'ultimo anno.

Rendimento vs Mercato: COH ha avuto una performance inferiore al mercato Australian che ha registrato un rendimento 17.2 % nell'ultimo anno.

Volatilità dei prezzi

Is COH's price volatile compared to industry and market?
COH volatility
COH Average Weekly Movement	2.7%
Medical Equipment Industry Average Movement	9.1%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.4%

Prezzo delle azioni stabile: COH non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 3% ) di COH è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

Fondato	I dipendenti	AMMINISTRATORE DELEGATO	Sito web
1981	5,047	Dig Howitt	www.cochlear.com

Cochlear Limited fornisce soluzioni uditive impiantabili per bambini e adulti in tutto il mondo. Offre sistemi di impianti cocleari, aggiornamenti dell'elaboratore del suono, sistemi a conduzione ossea, accessori e altri prodotti. L'azienda è stata fondata nel 1981 e ha sede a Sydney, in Australia.

Cochlear Limited Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di Cochlear con la sua capitalizzazione di mercato?
COH statistiche fondamentali
Capitalizzazione di mercato	AU$19.50b
Guadagni(TTM)	AU$356.80m
Ricavi(TTM)	AU$2.24b

53.7x

Rapporto P/E

8.6x

Rapporto P/S

COH è sopravvalutato?

Vedi Fair Value e analisi di valutazione

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
COH Conto economico (TTM)
Ricavi	AU$2.24b
Costo del fatturato	AU$562.10m
Profitto lordo	AU$1.67b
Altre spese	AU$1.32b
Guadagni	AU$356.80m

Ultimi guadagni dichiarati

Jun 30, 2024

Prossima data di guadagno

Feb 13, 2025

Utile per azione (EPS)	5.45
Margine lordo	74.86%
Margine di profitto netto	15.96%
Rapporto debito/patrimonio netto	0%

Come si è comportato COH nel lungo periodo?

Vedi performance storica e confronto

Dividendi

1.4%

Rendimento attuale del dividendo

75%

Rapporto di remunerazione

COH Panoramica delle azioni

Premi

Analisi del rischio

Cochlear Limited Concorrenti

ASX:SHL

AU$13.3b

ASX:RHC

AU$8.7b

ASX:AHC

AU$87.4m

ASX:ANN

AU$4.7b

Storia dei prezzi e prestazioni

Notizie e aggiornamenti recenti

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

CEO, MD exercised options and sold AU$3.1m worth of stock

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Now 20% overvalued

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

Recent updates

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

CEO, MD exercised options and sold AU$3.1m worth of stock

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

We Think Shareholders May Consider Being More Generous With Cochlear Limited's (ASX:COH) CEO Compensation Package

Now 20% overvalued

Cochlear Limited's (ASX:COH) Shareholders Might Be Looking For Exit

CEO, MD exercised options and sold AU$613k worth of stock

Stu Sayers to Appoint as President, Asia Pacific & Latin America of Cochlear Limited, Effective from 1 January 2025

Upcoming dividend of AU$2.10 per share

Final dividend of AU$2.10 announced

Cochlear Limited Announces Ordinary Dividend for the Period of Six Months Ended June 30, 2024, Payable on October 10, 2024

Cochlear Limited Just Missed EPS By 7.4%: Here's What Analysts Think Will Happen Next

Full year 2024 earnings: EPS misses analyst expectations

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Investors Could Be Concerned With Cochlear's (ASX:COH) Returns On Capital

Cochlear Limited Appoints Caroline Clarke as Non-Executive Director, Effective from 2 September 2024

Cochlear Limited Announces Executive Changes

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

Cochlear Limited (ASX:COH) acquired Oticon Medical A/s from Demant A/S (CPSE:DEMANT).

Cochlear Limited Announces Company Secretary Changes

Cochlear Limited Receives Fda Clearance to Lower the Age for the Osia System to 5-Year-Old

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Upcoming dividend of AU$2.00 per share

First half dividend increased to AU$2.00

Here's Why We Think Cochlear (ASX:COH) Is Well Worth Watching

First half 2024 earnings: EPS in line with expectations, revenues disappoint

Price target increased by 7.0% to AU$272

Cochlear (ASX:COH) Might Be Having Difficulty Using Its Capital Effectively

Is Cochlear Limited (ASX:COH) Expensive For A Reason? A Look At Its Intrinsic Value

Cochlear (ASX:COH) Could Be Struggling To Allocate Capital

Upcoming dividend of AU$1.75 per share at 1.2% yield

Cochlear Limited Introduces Next Generation Cochlear Osia System with Ability to Have MRI at 3.0 T

Cochlear Limited to Report Fiscal Year 2024 Results on Aug 15, 2024

Full year 2023 earnings: EPS in line with analyst expectations despite revenue beat

Cochlear Limited Announces Andrew Denver, Non-Executive Director Intention to Retire At AGM to Be Held on 17 October 2023

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear (ASX:COH) Seems To Use Debt Quite Sensibly

Upcoming dividend of AU$1.55 per share at 1.3% yield

Some Investors May Be Worried About Cochlear's (ASX:COH) Returns On Capital

Cochlear Limited Provides Earnings Outlook for the Year 2023

Cochlear Limited (ASX:COH) announces an Equity Buyback for AUD 75 million worth of its shares.

Is Cochlear (ASX:COH) A Risky Investment?

Cochlear Limited, Annual General Meeting, Oct 17, 2023

Is Cochlear Limited (ASX:COH) Worth AU$205 Based On Its Intrinsic Value?

FDA Approves Cochlear Limited's Nucleus 8 Sound Processor, Smaller, Smarter, Better Connected Cochlear Implant Technology

Key Executive recently bought AU$97k worth of stock

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Should Shareholders Reconsider Cochlear Limited's (ASX:COH) CEO Compensation Package?

Upcoming dividend of AU$1.45 per share

Cochlear's (ASX:COH) Upcoming Dividend Will Be Larger Than Last Year's

Here's Why Cochlear (ASX:COH) Can Manage Its Debt Responsibly

Full year 2022 earnings: EPS misses analyst expectations

Cochlear Announces Final Dividend Payable on 17 October 2022

The Returns On Capital At Cochlear (ASX:COH) Don't Inspire Confidence

Cochlear Limited Appoints Karen Penrose to Board, Effective on 1 July 2022

A Look At The Fair Value Of Cochlear Limited (ASX:COH)

Cochlear Limited, Annual General Meeting, Oct 18, 2022

Cochlear Limited to Report First Half, 2023 Results on Feb 15, 2023

Capital Allocation Trends At Cochlear (ASX:COH) Aren't Ideal